Rentokil Initial (RKLIF) Common Equity (2020 - 2025)

Rentokil Initial (RKLIF) has 6 years of Common Equity data on file, last reported at $5.5 billion in Q4 2025.

• Common Equity for Q4 2025 came in at $5.5 billion, up 1.22% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.5 billion (up 1.22% YoY), and the FY2025 annual result was $5.5 billion, up 3.76% from the prior year.
• Common Equity improved to $5.5 billion in Q4 2025 per RKLIF's latest filing, from $5.3 billion in the prior quarter.
• Over five years, Common Equity peaked at $5.5 billion in Q4 2025 and troughed at $1.7 billion in Q4 2021.
• A 5-year average of $4.5 billion and a median of $5.1 billion in 2023 frame the typical range for Common Equity.
• The sharpest annual moves came in 2022 and 2025: Common Equity jumped 182.1% in 2022, then gained 0.24% in 2025.
• A 5-year view of Common Equity shows it stood at $1.7 billion in 2021, then soared by 182.1% to $4.8 billion in 2022, then gained by 5.56% to $5.1 billion in 2023, then gained by 6.98% to $5.4 billion in 2024, then increased by 1.22% to $5.5 billion in 2025.
• Business Quant data shows RKLIF's Common Equity at $5.5 billion in Q4 2025, $5.3 billion in Q2 2025, and $5.4 billion in Q4 2024.